Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study

被引:0
|
作者
Se Rim Choi
Anna Shin
You-Jung Ha
Yun Jong Lee
Eun Bong Lee
Eun Ha Kang
机构
[1] Seoul National University Bundang Hospital,Division of Rheumatology, Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Seoul National University Hospital,Division of Rheumatology, Department of Internal Medicine
关键词
Rheumatoid arthritis; Janus kinase inhibitors; Tumor necrosis factor inhibitors; Infections; Asian;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [2] Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 589 - 590
  • [3] RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, S. R.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 716
  • [4] Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study
    A. Shin
    E.H. Park
    Y.-H. Dong
    Y.-J. Ha
    Y.J. Lee
    E.B. Lee
    Y.W. Song
    E.H. Kang
    [J]. Osteoporosis International, 2020, 31 : 2131 - 2139
  • [5] Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study
    Shin, A.
    Park, E. H.
    Dong, Y-H
    Ha, Y-J
    Lee, Y. J.
    Lee, E. B.
    Song, Y. W.
    Kang, E. H.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) : 2131 - 2139
  • [6] THE COMPARISON OF MALIGNANCY RISK BETWEEN JAK INHIBITORS AND TNF INHIBITORS IN MULTICENTER COHORT STUDY
    Uchida, T.
    Iwamoto, N.
    Fukui, S.
    Morimoto, S.
    Aramaki, T.
    Shomura, F.
    Aratake, K.
    Eguchi, K.
    Ueki, Y.
    Kawakami, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 717 - 718
  • [7] THE COMPARATIVE RISK OF OSTEOPOROTIC FRACTURES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TNF INHIBITORS VERSUS OTHER BIOLOGICS: A NATION-WIDE COHORT STUDY IN KOREA
    Shin, Anna
    Dong, Yaa-Hui
    Shin, Seunghwan
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    Kang, Eun Ha
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 726 - 726
  • [8] The Comparative Risk of Osteoporotic Fractures Among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Nation-wide Cohort Study in Korea
    Park, Eun Hye
    Shin, Anna
    Dong, Yaa-Hui
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong-Wook
    Kang, Eun Ha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] TREATMENT PERSISTENCE OF SUBCUTANEOUS TNF-ALPHA INHIBITORS AND JAK INHIBITORS AMONG AUSTRALIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Puig, Andrea
    Chien, Tirian
    O'Sullivan, Catherine
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 : 24 - 24
  • [10] Cancer risk with JAK inhibitors versus TNF inhibitors
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (05): : e252 - e252